In the US, the FDA is ready to announce the use of Remedicivir drug results positive

Posted on 30th Apr 2020 by rohit kumar

Washington. In the US, there have been many positive results of anti-viral drug Remadecivir for treatment with coronavirus. President Donald Trump and Infexious Disease Scientist Anthony Fauci have reported the results of early trials of Remedisvir as better. Fauci has hoped that this drug can curb the rate of rising deaths. The US Department of Food Drug and Administration (FDA) may soon announce its use.

 

Recovery rate of patients increased with Remedisivir

Earlier, Trump described hydroxychloroquine as an effective drug in Corona. However, it was then rejected by Doctor Fauci. Now after expressing the hope of the Fauci, this medicine is believed to be effective. Fauci said, “Use of this drug will help in increasing the recovery rate of patients. However, the National Institute of Allergy and Infectious Disease is conducting a more in-depth review of drug test results. The test indicated that remadecivir may reduce the recovery time by one third. That means a patient recovering in 15 days will be cured in five days. Currently, the study is expected to improve by 31 percent. Nevertheless it is very important. Because it has been proven that this drug can stop the virus. "Trump also called it a good sign. Said, "This is definitely a big positive event."

 

 

Gilead Sciences made Remedesvir for the treatment of Ebola

American biopharmaceutical company Gilead Sciences made Remedisvir during the Ebola epidemic. However, disappointment was at stake during its clinical trial in Africa. The special thing is that Remadecivir was never approved for treatment of any disease. According to Gilead, Remedisvir is not yet licensed or approved in the US or anywhere in the world.

 

Remedesivir production being increased

Gilead Sciences spokesman Ryan McKeel said the company could not speculate on what action the government would take. However, we are discussing with him the use of Remadecivir as a treatment for Covid-19 and positive results in the trial. Increasing the production of Remadecivir. If needed immediately, we can provide it.

 

Test done on 1000 people

 

Gilead Sciences has conducted a three-phase trial of this drug at 1000 volantiers. Fauci said that trials with the US began in Britain, Germany, Denmark, Spain and Greece. One thing is common that the use of this medicine is helping the patient recover. This drug inhibits a special type of enzyme in the body, by using which the coronavirus spreads in the body.

 

Thwarted in china

No positive effect was seen on Covid-19 patients in a study in China regarding this drug. The study was also published in the journal Lancet. However, it was said in the study that Remedisvir may prove useful to others elsewhere, but it did not show much effect in China. The study in China tested it on very few people. Dr. Bin Chao of the Capital Medical University of Beijing said, "Unfortunately, no benefit of Remedesiver was revealed in our trial."

 

What is placebo

 

Researchers say that 8% of the people who were given Remedisivir could not be saved. At the same time, 11% of the patients who survived were given placebo. Plesibo is a treatment in which the patient will recover on his own with strong willpower. For example, when patients complain about a disease and doctors do not find anything in the investigation, they give any sweet pill. In such a situation, the patient is confident that the doctor has given him the right medicine and his will power to recover becomes strong. Due to this, he gets well. This method of treatment is called placebo. It is not known whether Remedisvir has an effect on Covid-19. However, those who participated in the trial felt that he would recover from this drug, so his recovery speed increased. All this happened due to the will power of his mind.